Erratum: Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis

Detalles Bibliográficos
Autores principales: Harrison, C N, Vannucchi, A M, Kiladjian, J-J, Al-Ali, H K, Gisslinger, H, Knoops, L, Cervantes, F, Jones, M M, Sun, K, McQuitty, M, Stalbovskaya, V, Gopalakrishna, P, Barbui, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609269/
https://www.ncbi.nlm.nih.gov/pubmed/28248313
http://dx.doi.org/10.1038/leu.2016.323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609269/
https://www.ncbi.nlm.nih.gov/pubmed/28248313
http://dx.doi.org/10.1038/leu.2016.323

Ejemplares similares